secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001932393-26-000006
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare Q4 revenue up 7.1% to $5.7B; 2026 EPS guidance $4.95-$5.15
------------------------------------------------------------------------

- Q4 revenue $5.7B (+7.1% YoY, organic +4.8%); diluted EPS $1.29, adjusted EPS $1.44.
- Full year revenue $20.6B (+4.8%); diluted EPS $4.55, adjusted EPS $4.59; free cash flow $1.5B.
- 2026 guidance: organic revenue growth 3-4%, adj. EPS $4.95-$5.15, adj. EBIT margin 15.8-16.1%.
- Q4 net income $589M vs $720M prior; margins compressed due to tariff expense and unfavorable mix.
- Acquiring Intelerad for $2.3B, expected close H1 2026; closed Nihon Medi-Physics and icometrix in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239326000006/0001932393-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239326000006/gehc-20260204.htm
  HTML page:      https://secwatch.observer/filing/0001932393-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer